Tumor retention of 5-fluorouracil following irradiation observed using F-19 nuclear magnetic resonance spectroscopy

被引:17
作者
Blackstock, AW
Kwock, L
Branch, C
Zeman, EM
Tepper, JE
机构
[1] UNIV N CAROLINA, SCH MED, DEPT RADIAT ONCOL, CHAPEL HILL, NC USA
[2] UNIV N CAROLINA, SCH MED, DEPT RADIOL, CHAPEL HILL, NC USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1996年 / 36卷 / 03期
关键词
5-fluorouracil; F-19; NMR spectroscopy;
D O I
10.1016/S0360-3016(96)00356-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The combination of 5-fluorouracil (5FU) and radiation results in improved tumor control in a variety of gastrointestinal cancers. We propose the enhancement is related to radiation potentiating the antitumor effects of 5FU. To better understand the mechanism of the SFU-radiation interaction, F-19 nuclear magnetic resonance (NMR) spectroscopy experiments were performed to observed the tumor clearance and metabolism of 5FU, Methods and Materials: Experiments were performed on 10 3-6-week-old female (Nu/Nu) athymic nude mice. Flank tumors measuring approximately 1.0 cm in diameter 3 weeks following a subcutaneous injection of 1 x 10(6) human colon adenocarcinoma (HT-29) cells were studied. In our first group, all animals received an intravenous bolus injection of 5FU (100 mg/kg) immediately before spectroscopic analysis. Animals in the second group were first treated with a single tumor radiation dose of 10 Gy just before the 5FU injection and subsequent spectroscopy, Spectroscopic analysis was performed with a 2.0-T NMR spectroscopy system. Results: The tumor retention of 5FU was prolonged in animals receiving radiation before the drug infusion. The tumor clearance rate of the 5FU for nonirradiated animals was 0.0178 +/- 0.0082/min vs. 0.0055 +/- 0.0027/min for irradiated animals, reflecting a threefold reduction in drug clearance in the irradiated tumors, The difference was significant at p < 0.005. Conclusion: Our preliminary experiments suggest the enhanced cytotoxicity seen with concurrent 5FU and radiation is related to prolonged tumor retention of 5FU induced by radiation. This is consistent with the hypothesis that radiation is potentiating the cytotoxic effects of 5FU. Copyright (C) 1996 Elsevier Science Inc.
引用
收藏
页码:641 / 648
页数:8
相关论文
共 33 条
[11]   INVIVO MONITORING OF CHANGES IN 5-FLUOROURACIL METABOLISM INDUCED BY METHOTREXATE MEASURED BY F-19 NMR-SPECTROSCOPY [J].
KOUTCHER, JA ;
SAWYER, RC ;
KORNBLITH, AB ;
STOLFI, RL ;
MARTIN, DS ;
DEVITT, ML ;
COWBURN, D ;
YOUNG, CW .
MAGNETIC RESONANCE IN MEDICINE, 1991, 19 (01) :113-123
[12]   EFFECTIVE SURGICAL ADJUVANT THERAPY FOR HIGH-RISK RECTAL-CARCINOMA [J].
KROOK, JE ;
MOERTEL, CG ;
GUNDERSON, LL ;
WIEAND, HS ;
COLLINS, RT ;
BEART, RW ;
KUBISTA, TP ;
POON, MA ;
MEYERS, WC ;
MAILLIARD, JA ;
TWITO, DI ;
MORTON, RF ;
VEEDER, MH ;
WITZIG, TE ;
CHA, S ;
VIDYARTHI, SC .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (11) :709-715
[13]  
Lawrence, 1993, Semin Radiat Oncol, V3, P20, DOI 10.1016/S1053-4296(05)80074-8
[14]   COMBINED RADIATION-THERAPY AND 5-FLUOROURACIL FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF ORAL CAVITY AND OROPHARYNX - RANDOMIZED STUDY [J].
LO, TCM ;
WILEY, AL ;
ANSFIELD, FJ ;
BRANDENBURG, JH ;
DAVIS, HL ;
GOLLIN, FF ;
JOHNSON, RO ;
RAMIREZ, G ;
VERMUND, H .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1976, 126 (02) :229-235
[15]   SOLID TUMOR MODELS FOR ASSESSMENT OF DIFFERENT TREATMENT MODALITIES .4. COMBINED EFFECTS OF RADIATION AND 5-FLUOROURACIL [J].
LOONEY, WB ;
SCHAFFNER, JG ;
TREFIL, JS ;
KOVACS, CJ ;
HOPKINS, HA .
BRITISH JOURNAL OF CANCER, 1976, 34 (03) :254-261
[16]  
MALETMARTINO MC, 1986, CANCER CHEMOTH PHARM, V18, P5, DOI 10.1007/BF00253054
[17]   NEW APPROACH TO METABOLISM OF 5'-DEOXY-5-FLUOROURIDINE IN HUMANS WITH F-19 NMR [J].
MALETMARTINO, MC ;
MARTINO, R ;
LOPEZ, A ;
BETEILLE, JP ;
BON, M ;
BERNADOU, J ;
ARMAND, JP .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (01) :31-35
[18]   PREDICTION OF 5-FLUOROURACIL CYTO-TOXICITY TOWARDS THE WALKER CARCINOSARCOMA USING PEAK INTEGRALS OF FLUORONUCLEOTIDES MEASURED BY MRS INVIVO [J].
MCSHEEHY, PMJ ;
PRIOR, MJW ;
GRIFFITHS, JR .
BRITISH JOURNAL OF CANCER, 1989, 60 (03) :303-309
[19]  
MILLER EM, 1992, CANCER RES, V52, P1687
[20]  
MOERTEL CG, 1981, CANCER, V48, P1705, DOI 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO